ArticleThoracic cancer2023

Knockdown of circADAM9 inhibits cell progression and glycolysis by targeting the miR-1236-3p/FGF7 axis in breast cancer.

Bo Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.